We are enclosing herewith the Press Release on Contract Manufacturing Agreement with a company having top position in personal care segment on marketplace companies in the country for the ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Veerhealth Care has signed a Contract Manufacturing Agreement with India's top personal care marketplace company to produce private-label personal care products. Regulatory approvals are expected shortly, and commercial production is set to begin soon. The company has also resumed export dispatches after clearing a USFDA inspection, and is now operating at full capacity across its Vapi facility. New ventures include a hospital care division (ventilators, defibrillators, infusion pumps) and expansion into US medical device exports. Management has guided FY2025-26 revenue of ₹35-40 crores at a 10% PAT margin, with a longer-term target of ₹100 crores revenue over 24-36 months.
This is a positive development — the new contract strengthens order book visibility and utilization, while the USFDA clearance removes a key overhang that had hurt exports and earnings for the past 6-9 months. Together, these should support a recovery in revenue and profitability in upcoming quarters, though actual numbers will depend on timely regulatory approvals and ramp-up of production.